Co-prescription of medication for bipolar disorder and diabetes mellitus : a nationwide population based study with focus on gender differences
Data(s) |
01/01/2012
|
---|---|
Resumo |
<b>Background</b><br />Studies have shown a correlation between bipolar disorder and diabetes mellitus. It is unclear if this correlation is a part of common pathophysiological pathways, or if medication for bipolar disorder has negative effects on blood sugar regulation.<br /><b>Methods</b><br />The Norwegian prescription database was analyzed. Prescriptions for lithium, lamotrigine, carbamazepine and valproate were used as proxies for bipolar disorder. Prescriptions for insulin and oral anti-diabetic agents were used as proxies for diabetes mellitus. We explored the association between medication for bipolar disorder and diabetes medication by logistic regression<br /><b>Results</b><br />We found a strong association between concomitant use of medication to treat diabetes mellitus and mood stabilizers for the treatment of bipolar disorder. Females had a 30% higher risk compared to men of being treated for both disorders. Persons using oral anti-diabetic agents had higher odds of receiving valproate than either lithium or lamotrigine. Use of insulin as monotherapy seemed to have lower odds than oral anti-diabetic agents of co-prescription of mood stabilizers, compared to the general population.<br /><b>Conclusions</b><br />This study showed a strong association between the use of mood stabilizers and anti-diabetic agents. The association was stronger among women than men. |
Identificador | |
Idioma(s) |
eng |
Publicador |
BioMed Central |
Relação |
http://dro.deakin.edu.au/eserv/DU:30050626/berk-coprescriptionof-2012.pdf http://dx.doi.org/10.1186/1741-7015-10-148 |
Direitos |
2012, BioMed Central |
Palavras-Chave | #bipolar disorder #diabetes mellitus #gender |
Tipo |
Journal Article |